More recently, Clarke and colleagues proposed that reduced G6PD activity is associated with a lower risk of cerebral malaria, but in exchange for a higher risk of malarial anemia (Clarke et al. 2017), suggesting a delicate balance underlying the high frequency of G6PD polymorphism of populations in malaria-endemic regions. This evidence concerns the gene G6PD and malaria.